Cargando…

Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery

INTRODUCTION: Mild or moderate liver cirrhosis increases the risk of complications after cardiac surgery. Ascites is the most common complication associated with liver cirrhosis. However, the prognostic value of ascites on postoperative morbidity and mortality after cardiac surgery remains uninvesti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cizmic, Amila, Rahmanian, Parwis Baradaran, Gassa, Asmae, Kuhn, Elmar, Mader, Navid, Wahlers, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613375/
https://www.ncbi.nlm.nih.gov/pubmed/37898812
http://dx.doi.org/10.1186/s13019-023-02393-0
_version_ 1785128818240913408
author Cizmic, Amila
Rahmanian, Parwis Baradaran
Gassa, Asmae
Kuhn, Elmar
Mader, Navid
Wahlers, Thorsten
author_facet Cizmic, Amila
Rahmanian, Parwis Baradaran
Gassa, Asmae
Kuhn, Elmar
Mader, Navid
Wahlers, Thorsten
author_sort Cizmic, Amila
collection PubMed
description INTRODUCTION: Mild or moderate liver cirrhosis increases the risk of complications after cardiac surgery. Ascites is the most common complication associated with liver cirrhosis. However, the prognostic value of ascites on postoperative morbidity and mortality after cardiac surgery remains uninvestigated. METHODS: A retrospective study included 69 patients with preoperatively diagnosed liver cirrhosis who underwent cardiac surgery between January 2009 and January 2018 at the Department of Cardiothoracic Surgery, University Hospital of Cologne, Germany. The patients were divided into ascites and non-ascites groups based on preoperatively diagnosed ascites. Thirty-day mortality, postoperative complications, length of stay, and blood transfusions were analyzed postoperatively. RESULTS: Out of the total of 69 patients, 14 (21%) had preoperatively diagnosed ascites. Ascites group had more postoperative complications such as blood transfusions (packed red blood cells: 78.6% vs. 40.0%, p = 0.010; fresh frozen plasma: 57.1% vs. 29.1%, p = 0.049), acute kidney injury (78.6% vs. 45.5%, p = 0.027), longer ICU stay (8 vs. 3 days, p = 0.044) with prolonged mechanical ventilation (57.1% vs. 23.6%, p = 0.015) and tracheotomy (28.6% vs. 3.6%, p = 0.003). The 30-day mortality rate was significantly higher in the ascites group than in the non-ascites group (35.7% vs. 5.5%, p = 0.002). CONCLUSION: Ascites should be implemented in preoperative risk score assessments in cirrhotic patients undergoing cardiac surgery. Preoperative treatment of ascites could reduce the negative impact of ascites on postoperative complications after cardiac surgery. However, this needs to be thoroughly investigated in prospective randomized clinical trials. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10613375
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106133752023-10-30 Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery Cizmic, Amila Rahmanian, Parwis Baradaran Gassa, Asmae Kuhn, Elmar Mader, Navid Wahlers, Thorsten J Cardiothorac Surg Research INTRODUCTION: Mild or moderate liver cirrhosis increases the risk of complications after cardiac surgery. Ascites is the most common complication associated with liver cirrhosis. However, the prognostic value of ascites on postoperative morbidity and mortality after cardiac surgery remains uninvestigated. METHODS: A retrospective study included 69 patients with preoperatively diagnosed liver cirrhosis who underwent cardiac surgery between January 2009 and January 2018 at the Department of Cardiothoracic Surgery, University Hospital of Cologne, Germany. The patients were divided into ascites and non-ascites groups based on preoperatively diagnosed ascites. Thirty-day mortality, postoperative complications, length of stay, and blood transfusions were analyzed postoperatively. RESULTS: Out of the total of 69 patients, 14 (21%) had preoperatively diagnosed ascites. Ascites group had more postoperative complications such as blood transfusions (packed red blood cells: 78.6% vs. 40.0%, p = 0.010; fresh frozen plasma: 57.1% vs. 29.1%, p = 0.049), acute kidney injury (78.6% vs. 45.5%, p = 0.027), longer ICU stay (8 vs. 3 days, p = 0.044) with prolonged mechanical ventilation (57.1% vs. 23.6%, p = 0.015) and tracheotomy (28.6% vs. 3.6%, p = 0.003). The 30-day mortality rate was significantly higher in the ascites group than in the non-ascites group (35.7% vs. 5.5%, p = 0.002). CONCLUSION: Ascites should be implemented in preoperative risk score assessments in cirrhotic patients undergoing cardiac surgery. Preoperative treatment of ascites could reduce the negative impact of ascites on postoperative complications after cardiac surgery. However, this needs to be thoroughly investigated in prospective randomized clinical trials. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-10-28 /pmc/articles/PMC10613375/ /pubmed/37898812 http://dx.doi.org/10.1186/s13019-023-02393-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cizmic, Amila
Rahmanian, Parwis Baradaran
Gassa, Asmae
Kuhn, Elmar
Mader, Navid
Wahlers, Thorsten
Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
title Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
title_full Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
title_fullStr Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
title_full_unstemmed Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
title_short Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
title_sort prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613375/
https://www.ncbi.nlm.nih.gov/pubmed/37898812
http://dx.doi.org/10.1186/s13019-023-02393-0
work_keys_str_mv AT cizmicamila prognosticvalueofascitesinpatientswithlivercirrhosisundergoingcardiacsurgery
AT rahmanianparwisbaradaran prognosticvalueofascitesinpatientswithlivercirrhosisundergoingcardiacsurgery
AT gassaasmae prognosticvalueofascitesinpatientswithlivercirrhosisundergoingcardiacsurgery
AT kuhnelmar prognosticvalueofascitesinpatientswithlivercirrhosisundergoingcardiacsurgery
AT madernavid prognosticvalueofascitesinpatientswithlivercirrhosisundergoingcardiacsurgery
AT wahlersthorsten prognosticvalueofascitesinpatientswithlivercirrhosisundergoingcardiacsurgery